Chronic complement C3 gene expression in the CNS of transgenic mice with astrocyte-targeted interleukin-6 expression

GLIA

Volumn 18, Issue 2, 1996, Pages 107-117

  Barnum, Scott R ^a,b   Jones, Jennifer L ^a   Müller Ladner, Ulf ^b   Samimi, Ana ^c   Campbell, Ian L ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cytokines; Glial cells; Neurodegeneration

Indexed keywords

COMPLEMENT COMPONENT C3; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 6; MESSENGER RNA;

ANIMAL; ARTICLE; ASTROCYTE; BIOSYNTHESIS; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METABOLISM; MOUSE; NORTHERN BLOTTING; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ASTROCYTES; BLOTTING, NORTHERN; CENTRAL NERVOUS SYSTEM; COMPLEMENT C3; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERLEUKIN-6; MICE; MICE, TRANSGENIC; RNA, MESSENGER;

EID: 0030268026     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(199610)18:2<107::AID-GLIA3>3.0.CO;2-Y     Document Type: Article

References (45)

1. Aisen, P.S. and Davis, K.L. (1994) Inflammatory mechanisms in Alzheimer's disease: Implications for therapy. Am. J. Psychiatry, 151:1105-1113.
2. Badley, J.E., Bishop, G.A., St. John, T., and Frelinger, J.A. (1988) A simple, rapid method for the purification of poly A+ RNA. Biotechniques, 6:114-116.
3. Barnum, S.R. (1995) Complement biosynthesis in the centra] nervous system. Crit. Rev. Oral Biol. Med., 6:132-146.
4. Barnum, S.R. and Jones, J.L. (1994) Transforming growth factor-β1 inhibits inflammatory cytokine-induced C3 gene expression in astrocytes. J. Immunol., 152:765-773.
5. Barnum, S.R., Fey, G., and Tack, B.F. (1990) The biosynthesis and genetics of C3. Curr. Top. Microbiol. Immunol., 153:23-43.
6. Barnum, S.R., Jones, J.L., and Benveniste, E.N. (1992) Interferongamma regulation of C3 gene expression in human astroglioma cells. J. Neuroimmunol., 38:275-282.
7. Barnum, S.R., Jones, J.L., and Benveniste, E.N. (1993) Interleukin-1 and tumor necrosis factor mediated-regulation of C3 gene expression in human astroglioma cells. Glia, 7:225-236.
8. Benveniste, E.N. (1992) Inflammatory cytokines within the central nervous system: Sources, function and mechanism of action. Am. J. Physiol., 263(Cell Physiol 32):C1-C16.
9. Benveniste, E.N. (1995) The role of cytokines in multiple sclerosis/autoimmune encephalitis and other neurological disorders. In: Human Cytokines, Their role in Research and Therapy. B. Aggarwal and R. Puri, eds. Blackwell, Oxford, pp. 195-216.
10. Campbell, I.L. (1995) Neuropathogenic actions of cytokines assessed in transgenic mice. Int. J. Dev. Neurosci., 13:275-284.
11. Campbell, I.L., Abraham, C.R., Masliah, E., Kemper, P., Inglis, J.D. Oldstone, M.B.A., and Mucke, L. (1993) Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA, 90:10061-10065.
12. Campbell, I.L., Hobbs, M.V., Kemper, P., and Oldstone, M.B.A. (1994) Cerebral expression of multiple cytokine genes in mice with lymphocytic choriomeningitis. J. Immunol., 152:716-723.
13. Chiang, C.-S., Stalder, A., Samimi, A., and Campbell, I.L. (1994) Reactive gliosis as a consequence of interleukin-6 expression in the brain. Studies in transgenic mice. Dev. Neurosci., 16:212-221.
14. Danielson, P.E., Forss-Petter, S., Brow, M.A., Calavette, L., Douglass, J., Milner, J., and Sutcliffe, J.G. (1988) A cDNA clone of the rat mRNA encoding cyclophilin. DNA, 7:261-267.
15. Davis, R.E., Emmerling, M.R., Jaen, J.C., Moos, W.H., and Spiegel, K. (1993) Therapeutic intervention in dementia. Crit. Rev. Neurobiol., 7:41-83.
16. deBruijn, M.H.L. and Fey, G.H. (1985) Human complement component C3: cDNA coding sequence and derived primary structure. Proc. Natl. Acad. Sci. USA, 82:708-712.
17. Del Bigio, M.R. (1995) The ependyma: A protective barrier between brain and cerebrospinal fluid. Glia, 14:1-13.
18. Eikelenboom, P., Hack, C.E., Rozemuller, J.M., and Stam, F.C. (1989) Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch. [B], 56:259-262.
19. Gasque, P., Ischenko, A., Legoedec, J., Mauger, C., Schouft, M.T., and Fontaine, M. (1993) Expression of complement classical pathway by human glioma in culture. J. Biol. Chem., 268:25068-25074.
20. Gasque, P., Julen, N., Ischenko, A.M., Picot, C., Mauger, C., Chauzy, C., Ripoche, J., and Fontaine, M. (1992) Expression of complement components of the alternative pathway by glioma cell lines. J. Immunol., 149:1381-1388.
21. Gasque, P., Fontaine, M., and Morgan, B.P. (1995) Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J. Immunol., 154:4726-4733.
22. Hostetter, M.K., Krueger, R.A., and Schemling, D.J. (1984) The biochemistry of opsonization: Central role of the reactive thiolester of the third component of complement. J. Infect. Dis., 150:653-661.
23. Johnson, S.A., Lampert-Etchells, M., Pasinetti, G.M., Rozovsky, I., and Finch, C.E. (1992) Complement mRNA in the mammalian brain: Responses to Alzheimer's disease and experimental brain lesioning. Neurobiol. Aging, 13:641-648.
24. Lacy, M., Jones, J., Whittemore, S.R., Haviland, D.L., Wetsel, R.A., and Barnum, S.R. (1995) Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and fMLP by human astrocytes and microglia. J. Neuroimmunol., 61:71-77.
25. May, P.C., Lampert-Etchells, M. Johnson, S.A., Poorer, J., Masters, J.N., and Finch, C.E. (1990) Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat. Neuron, 5:831-839.
26. McGeer, P.L., Akiyama, H., and McGeer, E.G. (1989) Immune system response in Alzheimer's disease. Can. J. Neurol. Sci., 16:516-527.
27. McGeer, PL., Walker, D.G., Akiyama, H., Kawamata, T., Guan, A.L., Parker, C.J., Okada, N., and McGeer, E.G. (1991) Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain. Brain Res., 544:315-319.
28. McGeer, P.L., Kawamata, T., and Walker, D.F. (1992) Distribution of clusterin in Alzheimer brain tissue. Brain Res., 579:337-341.
29. Morgan, B.P. (1993) Complement in diseases of the central nervous system. In: Complement in Health and Disease. K. Whaley, M. Loos, and J.M. Weiler, eds. Kluwer Academic Press, London, pp. 353-375.
30. Müller-Eberhard, H.J. (1988) Molecular organization and function of the complement system. Annu. Rev. Biochem., 57:321-347.
31. Müller-Ladner, U., Kriegsmann, J. Tschopp, J., Gay, R.E., and Gay, S. (1995) Demonstration of granzyme A and perform messenger RNA in the synovium of patients with rheumatoid arthritis. Arthritis Rheum., 38:477-484.
32. Pasinetti, G.M., Johnson, S.A., Rozovsky, I., Lampert-Etchells, M., Morgan, D.G., Gordon, M.N., Morgan, T.E., Willoughby, D., and Finch, C.E. (1992) Complement C1q and C4 mRNAs responses to lesioning in the rat brain. Exp. Neurol., 118:117-125.
33. Perry, V.H. and Gordon, S. (1988) Macrophages and microglia in the nervous system. Trends Neurosci., 11:273-277.
34. Piddlesden, S.J., Storch, M.K., Hibbs, M., Freeman, A.M., Lassman, H., and Morgan, B.P. (1994) Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J. Immunol., 152:5477-5484.
35. Rogers, J., Cooper, N.R., Webster, S., Schultz, J., McGeer, P.L., Styren, S.D., Civin, W.H., Brachova, L., Bradt, B., Ward, P., and Lieberburg, I. (1992) Complement activation by β-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA, 89:10016-10020.
36. Rozemuller, J.M., Stam, F.C., and Eikelenboom, P. (1990) Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease. Neurosci. Lett., 119:75-78.
37. Rus, H.G., Kim, L.M., Niculescu, F.I., and Shin, M.L. (1992) Induction of C3 expression in astrocytes is regulated by cytokines and Newcastle disease virus. J. Immunol., 148:928-933.
38. Shin, M.L. and Koski, C.L. (1992) The complement system in demyelination. In: Myelin: Biology and Chemistry. R.E. Martenson, ed. CRC Press, Boca Raton, FL, pp. 801-831.
39. Steffensen, S.C., Campbell, I.L., and Henriksen. S.J. (1994) Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice. Brain Res., 652:149-153.
40. Ueki, A., Sai, T., Oka, H., Tabata, M., Hosokawa, K., and Mochizuki, Y. (1987) Biosynthesis and secretion of the third component of complement by human endothelial cells in vitro. Immunology, 61:11-14.
41. vanSnick, J., Cayphas S., Szikora, J.P., Renauld, J.C., Van Roost, E, Boon, T., and Simpson, R. J. (1988) cDNA cloning of murine interleukin-HP-1: Homology with human interleukin 6. Eur. J. Immunol., 18:193-197.
42. Volanakis, J.E. and Fearon, D.T. (1992) The molecular biology of the complement system. In: Arthritis and Allied Conditions - A Textbook of Rheumatology. D.J. McCarty, and W.J. Koopman, eds. Lea & Febiger, Philadelphia, pp. 445-467.
43. Walker, D.G. and McGeer, PL. (1992) Complement gene expression in human brain: Comparison between normal and Alzheimer disease cases. Mol. Brain Res., 14:109-116.
44. Warren, H.B., Pantazis, P., and Davies, P.F. (1987) The third component of complement is transcribed and secreted by cultured endothelial cells. Am. J. Pathol., 129:9-13.
45. Wilson, M.C. and Higgins, G.A. (1989) In situ hybridization. In: Neuromethods. Vol. 16. A.A. Boulton, G.B. Baker, and A.T. Campagnoni, eds. Humana, Clifton, NJ, pp. 239-284.